4.8 Letter

Incorporating biomarkers into clinical trial designs: points to consider

Journal

NATURE BIOTECHNOLOGY
Volume 30, Issue 7, Pages 596-599

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2296

Keywords

-

Ask authors/readers for more resources

In an environment where the regulatory and reimbursement authorities continue to raise the bar for new oncology therapies, how are sponsors adapting clinical trial designs?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available